Immunosuppressants Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 01
SKU : PH4059
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What is the expected CAGR of the global immunosuppressants drugs market?
The global immunosuppressants drugs market is expected to reach a high CAGR of 4.0% during the forecast period (2023-2030).
What are the key drivers of the immunosuppressants drugs market?
The key drivers of the immunosuppressants drugs market include the increasing prevalence of autoimmune diseases, the rising number of organ transplants, and technological advancements in tissue engineering and organ transplantation.
Which segment is expected to grow the fastest in the immunosuppressants drugs market?
The calcineurin inhibitors segment is expected to grow at the fastest CAGR during the forecast period (2021-2028). This is due to its wide applications, including utilization in organ transplant recipients and for the treatment of autoimmune diseases.
Who are the Key players of immunosuppressants drugs market?
Some of the key players which are contributing to the growth of the market include Astellas Pharma, Inc, Sanofi (Genzyme), Bristol-Myers Squibb Company, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc, GlaxoSmithKline Plc, Allergan Plc, Accord Healthcare Ltd and Mylan Laboratories, Inc.